Sign Up
OverviewAPI
Assertio Holdings, Inc. has successfully closed its acquisition of Spectrum Pharmaceuticals, Inc., aiming to bolster its market access and growth for all products. The acquisition is anticipated to be announced in the second quarter results call on August 3. Additionally, Jeffrey Vacirca, MD, FACP, has been appointed to Assertio's Board of Directors.

Ask a question